Laura R. Marks

2.3k total citations
49 papers, 1.6k citations indexed

About

Laura R. Marks is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Laura R. Marks has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 16 papers in Public Health, Environmental and Occupational Health and 14 papers in Infectious Diseases. Recurrent topics in Laura R. Marks's work include HIV, Drug Use, Sexual Risk (15 papers), Pneumonia and Respiratory Infections (13 papers) and Opioid Use Disorder Treatment (11 papers). Laura R. Marks is often cited by papers focused on HIV, Drug Use, Sexual Risk (15 papers), Pneumonia and Respiratory Infections (13 papers) and Opioid Use Disorder Treatment (11 papers). Laura R. Marks collaborates with scholars based in United States, Sweden and United Kingdom. Laura R. Marks's co-authors include Anders Håkansson, Michael J. Durkin, Ryan M. Reddinger, Stephen Y. Liang, Melinda M. Pettigrew, Bruce A. Davidson, Paul R. Knight, Ganapathi I. Parameswaran, Evan S. Schwarz and Nathanial S Nolan and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

Laura R. Marks

47 papers receiving 1.6k citations

Peers

Laura R. Marks
Robert Cunney Ireland
Jeffrey M. Bender United States
Stephen Young United States
Jina Lee South Korea
Ashish Bavdekar India
M. Ieven Belgium
Marco Cassone United States
Sheldon Campbell United States
Melinda M. Pettigrew United States
Timothy Neal United Kingdom
Robert Cunney Ireland
Laura R. Marks
Citations per year, relative to Laura R. Marks Laura R. Marks (= 1×) peers Robert Cunney

Countries citing papers authored by Laura R. Marks

Since Specialization
Citations

This map shows the geographic impact of Laura R. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura R. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura R. Marks more than expected).

Fields of papers citing papers by Laura R. Marks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura R. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura R. Marks. The network helps show where Laura R. Marks may publish in the future.

Co-authorship network of co-authors of Laura R. Marks

This figure shows the co-authorship network connecting the top 25 collaborators of Laura R. Marks. A scholar is included among the top collaborators of Laura R. Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura R. Marks. Laura R. Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schwartz, Drew J., et al.. (2023). Everything but the Kitchen Sink: An Analysis of Bacterial and Chemical Contaminants Found in Syringe Residue From People Who Inject Drugs. Open Forum Infectious Diseases. 11(1). ofad628–ofad628. 7 indexed citations
3.
Calcaterra, Susan L., Alexandra Savinkina, Laura R. Marks, et al.. (2023). Estimated Clinical Outcomes and Cost-effectiveness Associated With Provision of Addiction Treatment in US Primary Care Clinics. JAMA Network Open. 6(4). e237888–e237888. 7 indexed citations
4.
Wilcox, Melanie M., et al.. (2023). Answering the Call for Systems Change. SHILAP Revista de lepidopterología. 14(2). 2–24. 4 indexed citations
5.
Wurcel, Alysse G., Daniel C. DeSimone, Laura R. Marks, Larry M. Baddour, & Parham Sendi. (2023). Which trial do we need? Long-acting glycopeptides versus oral antibiotics for infective endocarditis in patients with substance use disorder. Clinical Microbiology and Infection. 29(8). 952–954. 3 indexed citations
6.
Atkinson, Andrew, Sena Sayood, Nathanial S Nolan, et al.. (2022). Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs. Clinical Infectious Diseases. 76(3). 487–496. 29 indexed citations
7.
8.
Nolan, Nathanial S, et al.. (2022). Experiences Using a Multidisciplinary Model for Treating Injection Drug Use Associated Infections: A Qualitative Study. Frontiers in Psychiatry. 13. 924672–924672. 2 indexed citations
9.
Ye, Yinyin, Adam Swensen, Yang Wang, et al.. (2021). A Pilot Study of Urine Proteomics in COVID-19–Associated Acute Kidney Injury. Kidney International Reports. 6(12). 3064–3069. 4 indexed citations
10.
Sayood, Sena, Laura R. Marks, Rupa Patel, et al.. (2021). Low Knowledge of HIV PrEP Within a Midwestern US Cohort of Persons who Inject Drugs. Open Forum Infectious Diseases. 9(1). ofab541–ofab541. 6 indexed citations
11.
Marks, Laura R., Juan J. Calix, Meghan A. Wallace, et al.. (2021). Staphylococcus aureus injection drug use-associated bloodstream infections are propagated by community outbreaks of diverse lineages. SHILAP Revista de lepidopterología. 1(1). 52–52. 7 indexed citations
12.
Marks, Laura R., Hilary Reno, Stephen Y. Liang, et al.. (2021). Value of Packaged Testing for Sexually Transmitted Infections for Persons who Inject Drugs Hospitalized With Serious Injection-Related Infections. Open Forum Infectious Diseases. 8(11). ofab489–ofab489. 11 indexed citations
13.
Marks, Laura R., Nathanial S Nolan, Stephen Y. Liang, Michael J. Durkin, & Melissa B. Weimer. (2021). Infectious Complications of Injection Drug Use. Medical Clinics of North America. 106(1). 187–200. 29 indexed citations
14.
Durkin, Michael J., Laura R. Marks, Nandini Raghuraman, et al.. (2021). The impact of hepatitis C on obstetric outcomes in an opioid use disorder-specific prenatal clinic. American Journal of Obstetrics and Gynecology. 226(1). S378–S379. 2 indexed citations
15.
Adams, Joëlla W., Alexandra Savinkina, Simeon D. Kimmel, et al.. (2021). 58. Cost-Effectiveness of Emerging Antibiotic Strategies for the Treatment of Drug-Use Associated Infective Endocarditis. Open Forum Infectious Diseases. 8(Supplement_1). S40–S40.
16.
17.
Marks, Laura R., David K. Warren, David B. Liss, et al.. (2019). A Comparison of Medication for Opioid Use Disorder Treatment Strategies for Persons Who Inject Drugs With Invasive Bacterial and Fungal Infections. The Journal of Infectious Diseases. 222(Supplement_5). S513–S520. 27 indexed citations
18.
Roche-Håkansson, Hazeline, et al.. (2019). The human milk protein-lipid complex HAMLET disrupts glycolysis and induces death in Streptococcus pneumoniae. Journal of Biological Chemistry. 294(51). 19511–19522. 10 indexed citations
19.
Marks, Laura R., et al.. (2013). Sensitization of Staphylococcus aureus to Methicillin and Other Antibiotics In Vitro and In Vivo in the Presence of HAMLET. PLoS ONE. 8(5). e63158–e63158. 52 indexed citations
20.
Marks, Laura R., et al.. (2012). The Human Milk Protein-Lipid Complex HAMLET Sensitizes Bacterial Pathogens to Traditional Antimicrobial Agents. PLoS ONE. 7(8). e43514–e43514. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Cunney Breakdown of academic impact, for papers by Jeffrey M. Bender Breakdown of academic impact, for papers by Stephen Young Breakdown of academic impact, for papers by Jina Lee Breakdown of academic impact, for papers by Ashish Bavdekar Breakdown of academic impact, for papers by M. Ieven Breakdown of academic impact, for papers by Marco Cassone Breakdown of academic impact, for papers by Sheldon Campbell Breakdown of academic impact, for papers by Melinda M. Pettigrew Breakdown of academic impact, for papers by Timothy Neal
Rankless by CCL
2026